{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T10:10:41Z","timestamp":1771409441758,"version":"3.50.1"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T00:00:00Z","timestamp":1771372800000},"content-version":"vor","delay-in-days":242,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T00:00:00Z","timestamp":1750464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>We aim to evaluate the implementation of the 2021 ESC Guidelines regarding screening and treatment of iron deficiency in patients with heart failure (HF) at Karolinska University Hospital.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Patients with left ventricular ejection fraction (LVEF) &amp;lt; 50% and New York Heart Association (NYHA) class II\u2013IV who visited Karolinska University Hospital in 2021 were identified through the registry SwedeHF. Data on patient characteristics, screening for iron deficiency, administration of ferric carboxymaltose (FCM) and HF medication were extracted from patients' health records. There were 261 patients registered whereof 141 (54%) were screened. Screened patients had lower LVEF [33% vs. 36% (P = 0.033)], higher N terminal pro brain natriuretic peptide levels [2880 ng\/L vs. 1960 ng\/L (P = 0.040)], higher prevalence of diabetes [31.9% vs. 20.0% (P = 0.030)] and were more often prescribed sodium-glucose co-transporter 2 inhibitors (SGLT2i) (49.6% vs. 25.8%) and loop diuretics [76.6% vs. 56.7% (both P &amp;lt; 0.001] compared with unscreened patients. Patients treated with intravenous iron had a higher NYHA class than untreated patients with an indication for treatment (P = 0.038).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In patients with HFrEF and HFmrEF, 54% were screened for iron deficiency. Screened patients had more advanced HF disease, possibly due to increased medical attention and higher compliance to guideline recommended treatment. We demonstrate that national quality registries can track outcomes and effectively enhance patient care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.15340","type":"journal-article","created":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T07:09:11Z","timestamp":1750489751000},"page":"3475-3482","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implementation of Guidelines for Intravenous Iron Therapy in Heart Failure Patients"],"prefix":"10.1093","volume":"12","author":[{"given":"Milou","family":"Gamage","sequence":"first","affiliation":[{"name":"Heart and Vascular Center, Karolinska University Hospital , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aristomenis","family":"Manouras","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Hage","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluigi","family":"Savarese","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Ljung","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Medicine Solna, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8541-623X","authenticated-orcid":false,"given":"Michael","family":"Melin","sequence":"additional","affiliation":[{"name":"Heart and Vascular Center, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Cardiology, Karolinska University Hospital , Stockholm ,","place":["Sweden"]},{"name":"Department of Laboratory Medicine Huddinge, Karolinska Institutet , Stockholm ,","place":["Sweden"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,21]]},"reference":[{"key":"2026021804191246200_ehf215340-bib-0001","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1093\/eurjpc\/zwaa147","article-title":"Burden of heart failure and underlying causes in 195 countries and territories from 1990 to 2017","volume":"28","author":"Bragazzi","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026021804191246200_ehf215340-bib-0002","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/CLEP.S170873","article-title":"Epidemiology of heart failure and trends in diagnostic work-up: a retrospective, population-based cohort study in Sweden","volume":"11","author":"Lindmark","year":"2019","journal-title":"Clin Epidemiol"},{"key":"2026021804191246200_ehf215340-bib-0003","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2022","journal-title":"Cardiovasc Res"},{"key":"2026021804191246200_ehf215340-bib-0004","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1053\/euhj.2002.3255","article-title":"Impact of heart failure and left ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic cardiac and medical disorders and a representative adult population","volume":"23","author":"Hobbs","year":"2002","journal-title":"Eur Heart J"},{"key":"2026021804191246200_ehf215340-bib-0005","volume-title":"DRG-statistik 2019 [Internet]","author":"Socialstyrelsen"},{"key":"2026021804191246200_ehf215340-bib-0006","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.ijcard.2013.12.028","article-title":"The annual global economic burden of heart failure","volume":"171","author":"Cook","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026021804191246200_ehf215340-bib-0007","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053806","article-title":"Healthcare resource utilisation and costs associated with a heart failure diagnosis: a retrospective, population-based cohort study in Sweden","volume":"11","author":"Boman","year":"2021","journal-title":"BMJ Open"},{"key":"2026021804191246200_ehf215340-bib-0008","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.jacc.2017.12.027","article-title":"The burden of iron deficiency in heart failure: therapeutic approach","volume":"71","author":"Rocha","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026021804191246200_ehf215340-bib-0009","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"key":"2026021804191246200_ehf215340-bib-0010","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur Heart J"},{"key":"2026021804191246200_ehf215340-bib-0011","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.118.030099","article-title":"Anemia and iron deficiency in heart failure: current concepts and emerging therapies","volume":"138","author":"Anand","year":"2018","journal-title":"Circulation"},{"key":"2026021804191246200_ehf215340-bib-0012","doi-asserted-by":"publisher","first-page":"2436","DOI":"10.1056\/NEJMoa0908355","article-title":"Ferric carboxymaltose in patients with heart failure and iron deficiency","volume":"361","author":"Anker","year":"2009","journal-title":"N Engl J Med"},{"key":"2026021804191246200_ehf215340-bib-0013","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur Heart J"},{"key":"2026021804191246200_ehf215340-bib-0014","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet"},{"key":"2026021804191246200_ehf215340-bib-0015","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0140-6736(22)02083-9","article-title":"Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial","volume":"400","author":"Kalra","year":"2022","journal-title":"Lancet"},{"key":"2026021804191246200_ehf215340-bib-0016","doi-asserted-by":"publisher","first-page":"3627","DOI":"10.1093\/eurheartj\/ehad195","article-title":"2023 focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"44","author":"McDonagh","year":"2023","journal-title":"Eur Heart J"},{"key":"2026021804191246200_ehf215340-bib-0017","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1002\/ejhf.2879","article-title":"Iron deficiency in heart failure: screening, prevalence, incidence and outcome data from the Swedish heart failure registry and the Stockholm CREAtinine measurements collaborative project","volume":"25","author":"Lindberg","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"2026021804191246200_ehf215340-bib-0018","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.1002\/ejhf.2338","article-title":"Phenotyping heart failure patients for iron deficiency and use of intravenous iron therapy: data from the Swedish heart failure registry","volume":"23","author":"Becher","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"2026021804191246200_ehf215340-bib-0019","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ahj.2023.08.005","article-title":"Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial","volume":"266","author":"Harrington","year":"2023","journal-title":"Am Heart J"},{"key":"2026021804191246200_ehf215340-bib-0020","doi-asserted-by":"publisher","first-page":"5077","DOI":"10.1093\/eurheartj\/ehad586","article-title":"Efficacy of ferric carboxymaltose in heart failure with iron deficiency: an individual patient data meta-analysis","volume":"44","author":"Ponikowski","year":"2023","journal-title":"Eur Heart J"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/5\/3475\/66969488\/eschf_12_5_3475.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/12\/5\/3475\/66969488\/eschf_12_5_3475.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,18]],"date-time":"2026-02-18T09:19:18Z","timestamp":1771406358000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/12\/5\/3475\/8488235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,21]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6,21]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.15340","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,10]]},"published":{"date-parts":[[2025,6,21]]},"assertion":[{"value":"2024-02-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}